• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体(PPARs)的差异表达:成年大鼠中PPAR-α、-β和-γ的组织分布

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat.

作者信息

Braissant O, Foufelle F, Scotto C, Dauça M, Wahli W

机构信息

Institut de Biologie Animale, Bâtiment de Biologie, Université de Lausanne, Switzerland.

出版信息

Endocrinology. 1996 Jan;137(1):354-66. doi: 10.1210/endo.137.1.8536636.

DOI:10.1210/endo.137.1.8536636
PMID:8536636
Abstract

Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor superfamily that can be activated by various xenobiotics and natural fatty acids. These transcription factors primarily regulate genes involved in lipid metabolism and also play a role in adipocyte differentiation. We present the expression patterns of the PPAR subtypes in the adult rat, determined by in situ hybridization using specific probes for PPAR-alpha, -beta and -gamma, and by immunohistochemistry using a polyclonal antibody that recognizes the three rat PPAR subtypes. In numerous cell types from either ectodermal, mesodermal, or endodermal origin, PPARs are coexpressed, with relative levels varying between them from one cell type to the other. PPAR-alpha is highly expressed in hepatocytes, cardiomyocytes, enterocytes, and the proximal tubule cells of kidney. PPAR-beta is expressed ubiquitously and often at higher levels than PPAR-alpha and -gamma. PPAR-gamma is expressed predominantly in adipose tissue and the immune system. Our results suggest new potential directions to investigate the functions of the different PPAR subtypes.

摘要

过氧化物酶体增殖物激活受体(PPARs)是核激素受体超家族的成员,可被多种外源性物质和天然脂肪酸激活。这些转录因子主要调节参与脂质代谢的基因,并且在脂肪细胞分化中也发挥作用。我们通过使用针对PPAR-α、-β和-γ的特异性探针进行原位杂交,以及使用识别三种大鼠PPAR亚型的多克隆抗体进行免疫组织化学,展示了成年大鼠中PPAR亚型的表达模式。在源自外胚层、中胚层或内胚层的多种细胞类型中,PPARs共同表达,它们之间的相对水平因细胞类型而异。PPAR-α在肝细胞、心肌细胞、肠上皮细胞和肾近端小管细胞中高度表达。PPAR-β广泛表达,且其表达水平通常高于PPAR-α和-γ。PPAR-γ主要在脂肪组织和免疫系统中表达。我们的结果为研究不同PPAR亚型的功能提示了新的潜在方向。

相似文献

1
Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat.过氧化物酶体增殖物激活受体(PPARs)的差异表达:成年大鼠中PPAR-α、-β和-γ的组织分布
Endocrinology. 1996 Jan;137(1):354-66. doi: 10.1210/endo.137.1.8536636.
2
Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development.过氧化物酶体增殖物激活受体α、β和γ在大鼠胚胎发育过程中的差异表达。
Endocrinology. 1998 Jun;139(6):2748-54. doi: 10.1210/endo.139.6.6049.
3
Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver.大鼠肝脏中过氧化物酶体增殖物激活受体-α mRNA的调控
Arch Biochem Biophys. 1996 Feb 15;326(2):281-9. doi: 10.1006/abbi.1996.0077.
4
Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.小鼠肥胖时肝脏中过氧化物酶体增殖物激活受体(PPAR-α)和PPAR-γ信使核糖核酸表达上调:曲格列酮诱导肥胖糖尿病小鼠肝脏中PPAR-γ反应性脂肪组织特异性基因的表达。
Endocrinology. 2000 Nov;141(11):4021-31. doi: 10.1210/endo.141.11.7771.
5
Expression of peroxisome proliferator-activated receptors in the liver of gray mullet (Mugil cephalus).鲻鱼(Mugil cephalus)肝脏中过氧化物酶体增殖物激活受体的表达
Acta Histochem. 2004 Feb;106(1):11-9. doi: 10.1016/j.acthis.2003.09.002.
6
Expression of peroxisome proliferator-activated receptors in zebrafish (Danio rerio).过氧化物酶体增殖物激活受体在斑马鱼(Danio rerio)中的表达。
Histochem Cell Biol. 2002 Sep;118(3):231-9. doi: 10.1007/s00418-002-0434-y. Epub 2002 Jul 4.
7
[Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].过氧化物酶体增殖物激活受体(PPARS)在脂质调节和炎症控制中的作用
J Soc Biol. 2002;196(1):47-52.
8
Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease.针对肾脏和泌尿系统疾病中的过氧化物酶体增殖物激活受体(PPARs)
Minerva Urol Nefrol. 2002 Jun;54(2):65-79.
9
Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.大鼠皮质神经元中过氧化物酶体增殖物激活受体(PPARs)和视黄酸受体(RXRs)的表达
Neuroscience. 2005;130(2):325-37. doi: 10.1016/j.neuroscience.2004.09.043.
10
Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action.过氧化物酶体增殖物激活受体(PPARs)在人体骨骼肌和脂肪组织中的分布:与胰岛素作用的关系。
Diabetologia. 2000 Mar;43(3):304-11. doi: 10.1007/s001250050048.

引用本文的文献

1
Pemafibrate Ameliorates Steatotic Liver Disease Regardless of Endothelial Dysfunction in Mice.无论小鼠是否存在内皮功能障碍,培马贝特均可改善脂肪性肝病。
Antioxidants (Basel). 2025 Jul 20;14(7):891. doi: 10.3390/antiox14070891.
2
Pharmacological inhibition of Peroxisome Proliferation-Activated Receptor Delta (PPARδ) imparts selective leukemia cell death.过氧化物酶体增殖物激活受体δ(PPARδ)的药理学抑制可导致选择性白血病细胞死亡。
Cancer Metab. 2025 Jul 25;13(1):36. doi: 10.1186/s40170-025-00402-5.
3
Role of peroxisome proliferator-activated receptor alpha in neurodegenerative diseases and other neurological disorders: Clinical application prospects.
过氧化物酶体增殖物激活受体α在神经退行性疾病和其他神经系统疾病中的作用:临床应用前景
Neural Regen Res. 2025 Jun 19. doi: 10.4103/NRR.NRR-D-24-01371.
4
Ethnopharmacological Profile, Phytochemistry and Therapeutic Potential of L. for the Treatment of Neurological Disorders.L. 用于治疗神经系统疾病的民族药理学概况、植物化学及治疗潜力
J Nutr Metab. 2025 Jun 11;2025:2275526. doi: 10.1155/jnme/2275526. eCollection 2025.
5
Predicting peroxisome proliferator-activated receptor gamma potency of small molecules: a synergistic consensus model and deep learning binding affinity approach powered by Enalos Cloud Platform.预测小分子的过氧化物酶体增殖物激活受体γ活性:一种由Enalos云平台驱动的协同共识模型和深度学习结合亲和力方法
Mol Divers. 2025 Jun 14. doi: 10.1007/s11030-025-11230-6.
6
Peroxisome Proliferator-Activated Receptors (PPARs) May Mediate the Neuroactive Effects of Probiotic Metabolites: An In Silico Approach.过氧化物酶体增殖物激活受体(PPARs)可能介导益生菌代谢产物的神经活性作用:一种计算机模拟方法
Int J Mol Sci. 2025 May 9;26(10):4507. doi: 10.3390/ijms26104507.
7
Effect of pemafibrate in reducing intestinal long-chain fatty acid absorption and hepatic fibrosis in metabolic dysfunction-associated steatohepatitis rats.匹伐他汀对代谢功能障碍相关脂肪性肝炎大鼠肠道长链脂肪酸吸收及肝纤维化的影响。
BMC Gastroenterol. 2025 May 19;25(1):385. doi: 10.1186/s12876-025-03967-z.
8
Endocrine-disrupting chemicals as prostate carcinogens.作为前列腺致癌物的内分泌干扰化学物质。
Nat Rev Urol. 2025 May 16. doi: 10.1038/s41585-025-01031-9.
9
Chromenochalcones: a comprehensive review on developments towards a medicinal perspective.色烯查耳酮:从医学角度对其研究进展的全面综述
RSC Med Chem. 2025 Apr 21. doi: 10.1039/d5md00062a.
10
Quantitative 3D histochemistry reveals region-specific amyloid-β reduction by the antidiabetic drug netoglitazone.定量三维组织化学显示抗糖尿病药物奈格列酮可使特定区域的β淀粉样蛋白减少。
PLoS One. 2025 May 6;20(5):e0309489. doi: 10.1371/journal.pone.0309489. eCollection 2025.